Skip to content

Clinical trials

Patellofemoral Pain Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Patellofemoral Pain Syndrome Clear all

294 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20042
20054
20065
20072
20083
20093
20101
20115
20126
20136
20149
201514
201612
201723
20189
201917
202015
202117
202220
202328
202430
202523
202638

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed154
Unknown status60
Recruiting26
Not yet recruiting24
Active, not recruiting12
Terminated10
Enrolling by invitation4
Withdrawn4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cairo University28
Riphah International University25
National Taiwan University Hospital9
Aalborg University5
Hacettepe University5
Ahram Canadian University4
Beijing Sport University4
Nationwide Children's Hospital4
Peking University Third Hospital4
Universidade Federal do Ceara4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Patellofemoral Pain Syndrome294
Pain23
Anterior Cruciate Ligament Injuries4
Kinesiophobia4
Ankle Injuries3
Chondromalacia Patellae3
Congenital Abnormalities3
Knee Injuries3
Medial Tibial Stress Syndrome3
Musculoskeletal Diseases3

Trials

Showing 26 to 50 of 294. Each trial links to its page on Pharma Observatory.

194 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.